Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: SPERO THERAPEUTICS, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2018-07-12 to 2025-12-31
Current total value of award: $31675699
Description: ADVANCE THE DEVELOPMENT OF SPR994 AS AN ORAL THERAPY FOR USE IN ADULTS TO TREAT COMPLICATED URINARY TRACT INFECTIONS (CUTIS), INCLUDING THOSE CAUSED BY DRUG RESISTANT BACTERIA